CML is a classical stem cell-driven cancer, with BCR::ABL1 translocation arising in an HSC, and the transformed LSC driving a myeloproliferative phenotype through constitutive kinase activity. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.